Date: 2009-07-17
Beyond labeling, the National Animal Supplement Council (NASC) has established multiple procedures that members must follow to help address safety and regulatory concerns. These include:
- Products must meet specified current good manufacturing practices (cGMPs) covering aspects such as processing, ingredient and product testing and record-keeping. With a few exceptions, NASC requirements are roughly equivalent to cGMPs required for human dietary supplements under FDA regulations (21 CFR 111);
- Products must be “drug listed” with FDA. This usually prompts an FDA inspection of the manufacturing facilities, company records, formulation and labeling, etc.;
- Members must convey adverse event reports from use of products to NASC in a timely manner for inclusion in its database. The database is open to review by FDA and state regulators;
- Members must submit to NASC audits to verify compliance with the above.